Trials / Conditions / Neuromyelitis Optica (NMO)
Neuromyelitis Optica (NMO)
3 registered clinical trials studyying Neuromyelitis Optica (NMO) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD NCT07132398 | Tianjin Medical University General Hospital | Phase 3 |
| Completed | Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Opti NCT02073279 | Hoffmann-La Roche | Phase 3 |
| Completed | Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis O NCT02028884 | Hoffmann-La Roche | Phase 3 |